A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Rebecca C. Coll; Avril A. B. Robertson; Jae Jin Chae; Sarah Higgins; Raúl Muñoz-Planillo; Marco Inserra; Irina Vetter; Lara S. Dungan; Brian G. Monks; Andrea Stutz; Daniel E. Croker; Mark S. Butler; Moritz Haneklaus; Caroline E. Sutton; Gabriel Núñez; Eicke Latz; Daniel L. Kastner; Kingston H. G. Mills; Seth L. Masters; Kate Schroder; Matthew A. Cooper; Luke O'neill

doi:10.1038/nm.3806

Article2012

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Haitao Wen, Jenny P.‐Y. Ting, Luke O'neill

Nature Immunology

Article2012

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Haitao Wen, Jenny P.‐Y. Ting, Luke O'neill

Carolina Digital Repository (University of North Carolina at Chapel Hill)

Article2014

Cytokine release inhibitor drug, CRID3, inhibits the NLRP3 inflammasome in glia

Colin Dempsey, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, Luke O'neill, Marina A. Lynch

Journal of Neuroimmunology

Article2016

Nlrp3 Inflammasome-Mediated, Il-1 beta-Dependent Inflammatory Responses Drive Severe, Steroid-Insensitive Asthma

R. Y. Kim, James Pinkerton, Ama‐Tawiah Essilfie, Avril A. B. Robertson, Katherine J. Baines, Jemma Mayall, Malcolm R. Starkey, Peter Wark, Peter G. Gibson, Luke O'neill, Matthew A. Cooper, Jay C. Horvat, Philip M. Hansbro

American Journal of Respiratory and Critical Care Medicine

Article2016

Nlrp3 Inflammasome-Mediated, Il-1 beta-Dependent Inflammatory Responses Drive Severe, Steroid-Insensitive Asthma

R. Y. Kim, James Pinkerton, Ama‐Tawiah Essilfie, Avril A. B. Robertson, Katherine J. Baines, Jemma Mayall, Malcolm R. Starkey, Peter Wark, Peter G. Gibson, Luke O'neill, Matthew A. Cooper, Jay C. Horvat, Philip M. Hansbro

American Journal of Respiratory and Critical Care Medicine

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Abstract

Discussion(0)

Related publications

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Cytokine release inhibitor drug, CRID3, inhibits the NLRP3 inflammasome in glia

Nlrp3 Inflammasome-Mediated, Il-1 beta-Dependent Inflammatory Responses Drive Severe, Steroid-Insensitive Asthma

Nlrp3 Inflammasome-Mediated, Il-1 beta-Dependent Inflammatory Responses Drive Severe, Steroid-Insensitive Asthma